The State Street Consumer Staples Select Sector SPDR ETF (NYSEMKT:XLP) and the Invesco Food & Beverage ETF (NYSEMKT:PBJ) both target the U.S. consumer sector, but XLP offers broader staples exposure at a lower cost and higher yield, while PBJ focuses on food and beverage with a more diversified sector mix and higher trading friction. XLP and PBJ both give investors access to U.S. companies in food, beverage, and consumer defensive industries, but their approaches and underlying holdings differ. This comp ...

The trading week is about to serve up a heavy dose of consumer reality with a trio of earnings reports from the titans of fast food, consumer staples, and beverages. McDonald’s (MCD), Kraft Heinz (KHC), and Anheuser-Busch InBev (BUD) are all scheduled to report within a tight window starting early Wednesday, Feb. 11, providing a comprehensive look at how the American consumer is handling the high-cost economy of 2026. This cluster of reports functions like a post-Super Bowl feast for analysts, revealing ...

Listen on the go! A daily podcast of Wall Street Breakfast will be available by 8:00 a.m. on Seeking Alpha, iTunes, Spotify.Getty Images Good morning! Here's the latest in trending:Tech earnings: AMD (AMD) shares are falling despite results and outlook topping estimates. Alphabet (GOOGL) and Qualcomm (QCOM) due later today.On the Hill: The House passed legislation to fund most of the government for the rest of the fiscal year, ending the four-day partial shutdown.Tensions simmer: The U.S. Navy shot down an ...

Group 1 - The Procter & Gamble Company (NYSE:PG) shares have decreased by 10% over the past year but have increased by 5.7% year-to-date [2] - Barclays raised the share price target for Procter & Gamble to $155 from $151 while maintaining an Equal Weight rating, citing pressures from oil and currency as potential headwinds in 2026 [2] - UBS lowered its share price target for Procter & Gamble to $161 from $176 but kept a Buy rating, reflecting concerns over uncertain market conditions for consumer staples stocks in late 2026 [2] - JPMorgan expressed optimism about Procter & Gamble, suggesting that the company could see sales growth acceleration and improved margins [2] - Jim Cramer supports the positive outlook from JPMorgan, highlighting the potential impact of the new CEO on the company's performance [3] Group 2 - The new CEO of Procter & Gamble is described as having an international orientation, discussing markets such as Brazil, Mexico, and China, which indicates a shift in the company's focus [3] - There is a belief that while Procter & Gamble has investment potential, certain AI stocks may offer higher returns with limited downside risk [4]

We recently published 14 Stocks on Jim Cramer’s Radar.  The Procter & Gamble Company (NYSE:PG) is one of the stocks on Jim Cramer's radar. The Procter & Gamble Company (NYSE:PG) is one of the largest consumer goods companies in the world. Its shares are down by more than 11% over the past year and are up by 5.4% year-to-date. In mid-January, investment bank UBS cut the firm’s share price target to $161 from $176 and kept a Buy rating on the shares. The financial firm commented that while The Procter & Gam ...

Core Insights - Procter & Gamble (P&G) has seen its stock increase over 10,000% since the 1980s, but it has struggled to attract market attention recently [1] - The company's recent quarterly earnings are not expected to significantly change its market status, with geopolitical factors influencing investor behavior [2] Business Backdrop - Over the past decade, P&G has focused on a tighter portfolio of essential brands, moving away from food and smaller brands, which has allowed it to outperform competitors like Unilever [4] - Growth is now more reliant on pricing, product mix, and cost control rather than volume gains from innovation, making the company vulnerable in a tightening consumer environment [5] Quarterly Performance - For the quarter ending December 31, P&G reported $22.2 billion in sales, a 1% increase from the previous year, but organic sales remained flat due to a 1% drop in volume [6] - The decline in volume affected various segments, with Baby, Feminine, and Family Care seeing a 4% drop in organic sales, while Health Care and Beauty performed better due to premium products [7] Margin Pressures - Tariffs have significantly impacted P&G's margins, with an expected $400 million in after-tax tariff costs for fiscal 2026, leading to a 60 basis point decline in margins [8]

Core Viewpoint - A class action lawsuit has been filed against Perrigo Company plc for failing to disclose significant issues in its infant formula business, leading to overstated financial results and subsequent stock price decline [2][8]. Allegation Details - The lawsuit alleges that Perrigo did not disclose: 1. Significant underinvestment in maintenance and operational improvements in the infant formula business acquired from Nestlé [8]. 2. The need for substantial capital and operational expenditures beyond previously stated estimates to remediate the infant formula business [8]. 3. Significant manufacturing deficiencies in the infant formula facility [8]. 4. The impact of these issues resulted in overstated financial results, including earnings and cash flow [8]. Financial Impact - On November 5, 2025, Perrigo announced disappointing financial results for Q3 2025, leading to a reduction in its fiscal year 2025 outlook primarily due to challenges in the infant formula industry [8]. - Following this announcement, Perrigo's stock price fell by $5.09, or 25.2%, closing at $15.10 per share on the same day [8].

Group 1: Earnings Overview - The Q4 earnings season is expected to begin with major banks like JPMorgan Chase, BNY Mellon, Bank of America, Wells Fargo, and Citigroup reporting results, with corporate earnings expectations strengthening over recent quarters [1] - Total S&P 500 earnings for Q4 2025 are projected to rise by 7.9% year over year, supported by an 8.2% increase in revenues, marking the 10th consecutive quarter of positive earnings growth for the index [2] Group 2: Sector Performance - Aerospace, tech, and finance sectors are anticipated to perform well in Q4, while seven of the 16 Zacks sectors are expected to underperform, notably Autos with a projected earnings decline of 24%, Transportation with an 8.5% decline, and Consumer Staples with a 4.1% decline [3] - The Auto sector is expected to see a 24% decline in earnings due to a 7.3% decrease in revenues, following a 20.7% earnings loss in Q3 2025 despite 4% revenue growth [4] - The Transportation sector is projected to lose 8.5% in earnings with only 1.2% revenue growth, following a minimal earnings gain of 0.3% in Q3 [7] - The Consumer Staples sector is expected to post a 4% earnings decline despite 2.4% revenue growth, following a 0.9% earnings drop in Q3 [8] Group 3: Sector Challenges - The Auto sector faces challenges from increased costs due to tariffs and softening demand, with lower-income buyers likely to pull back on purchases [6] - The Transportation sector is experiencing earnings pressure from subdued freight demand, attributed to earlier inventory buildup from trade policy uncertainty [7] - Consumer Staples companies are under pressure from inflation, a soft labor market, and falling affordability, impacting their pricing power [8]

Core Viewpoint - The Procter & Gamble Company (NYSE:PG) is recognized as one of the best beauty stocks to invest in currently, despite facing challenges in the consumer staples sector in 2026 [1]. Group 1: Analyst Insights - TD Cowen analyst Robert Moskow has reduced the price target for Procter & Gamble from $168 to $150 while maintaining a buy rating, reflecting concerns about the consumer staples sector's performance in 2026 [2]. - The firm projects that volume growth for large-cap consumer staples will remain stagnant, with an expected decline of -0.9% in 2025, and pricing is anticipated to remain subdued [2]. Group 2: Regulatory Developments - Texas Attorney General Ken Paxton announced that Procter & Gamble has reached an agreement regarding the marketing and packaging of Crest children's toothpaste, ensuring accurate representation of fluoride content [3]. - The updated packaging for Crest children's toothpaste took effect on January 1, 2026, and P&G is required to comply with the agreement for five years [3]. Group 3: Company Overview - Procter & Gamble is one of the largest consumer product manufacturers globally, with annual revenues estimated at approximately $85 billion [4]. - While the company shows potential as an investment, there are suggestions that certain AI stocks may offer better upside potential with lower downside risk [4].

Core Viewpoint - Rosen Law Firm is reminding investors who purchased Perrigo Company plc securities between February 27, 2023, and November 4, 2025, of the January 16, 2026, lead plaintiff deadline for a class action lawsuit [1] Group 1: Class Action Details - Investors who purchased Perrigo securities during the specified class period may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [1] - A class action lawsuit has already been filed, and interested parties must move the Court to serve as lead plaintiff by January 16, 2026 [2] - The lead plaintiff acts on behalf of other class members in directing the litigation [2] Group 2: Rosen Law Firm's Credentials - Rosen Law Firm emphasizes the importance of selecting qualified counsel with a successful track record in securities class actions [3] - The firm has achieved significant settlements, including the largest securities class action settlement against a Chinese company and has been ranked highly for securities class action settlements since 2013 [3] - In 2019, the firm secured over $438 million for investors, showcasing its capability in recovering funds for clients [3] Group 3: Case Allegations - The lawsuit alleges that Perrigo made materially false and misleading statements regarding its infant formula business acquired from Nestlé, which suffered from underinvestment and required substantial capital expenditures [4] - It is claimed that there were significant manufacturing deficiencies in Perrigo's infant formula facility, leading to overstated financial results [4] - The misleading statements about Perrigo's business operations resulted in investor damages when the true details became public [4]